Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device

These preliminary data from an ongoing first-in-human phase 1/2, open-label study provide proof-of-concept that pluripotent stem cell-derived pancreatic endoderm cells (PEC-01) engrafted in type 1 diabetes patients become islet cells releasing insulin in a physiologically regulated fashion. In this...

Descripción completa

Detalles Bibliográficos
Autores principales: Shapiro, A.M. James, Thompson, David, Donner, Thomas W., Bellin, Melena D., Hsueh, Willa, Pettus, Jeremy, Wilensky, Jon, Daniels, Mark, Wang, Richard M., Brandon, Eugene P., Jaiman, Manasi S., Kroon, Evert J., D’Amour, Kevin A., Foyt, Howard L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714853/
https://www.ncbi.nlm.nih.gov/pubmed/35028608
http://dx.doi.org/10.1016/j.xcrm.2021.100466

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714853/
https://www.ncbi.nlm.nih.gov/pubmed/35028608
http://dx.doi.org/10.1016/j.xcrm.2021.100466

Ejemplares similares